Key Dates

Related Announcements

PAR-17-496 Intervention Research to Improve Native American Health (R01 Clinical Trial Optional)

PAR-17-464 Research to Improve Native American Health (R21 Clinical Trials Optional)

Issued by

Purpose

The purpose of this Notice is to revise a “receipt date” of the PAR-17-496, and PAR-17-464.

I. Part 1 Key Dates in PAR-17-496 and PAR-17-464 Currently Reads:

Application Due Date(s):
May 14, 2018; May 14, 2019; May 14, 2020

II. Part 1 Key Dates in PAR-17-496 and PAR-17-464 Modified (by this Notice) to Read (in italics):

Application Due Date(s):
May 14, 2018; May 14, 2019; August 14, 2020

III. Section IV.7 (Post Submission Materials) of the Funding Opportunity Announcements (PAR-17-496 and PAR-17-464) Modified (by this Notice) to Read (in italics):

Applicants are required to follow the instructions for post-submission materials, as described in the policy to be read with the following changes due to the on going COVID-19 situation -

Letters of Support:

Letters of Support may be submitted as late as September 14, 2020.
Letters of Support include tribal resolutions or equivalent document from each participating tribe and community, if applicable. Detail information on the letters of support can be found in the original funding announcement. If the Letters of Support are being submitted late, each letter should contain the following:
Principal Investigator Name:
Principal Investigator email:
Principal Investigator phone number:
Title of the project:
Grant number (if applicable):

NOTE: All other aspects of these funding opportunity announcements (PAR-17-496 and PAR-17-464) remain unchanged.

Inquiries

Please direct all inquiries to:

Shobha Srinivasan, Ph.D.,
National Cancer Institute (NCI)
Telephone: 240-276-6938
Email: [email protected]